PDSB Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2020-04-29 | 2018 | Frank Bedu-Addo, Ph.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | Frank Bedu-Addo, Ph.D. Chief Executive Officer | 356,250 | 395,000 | 0 | 0 | 0 | 2,583,760 |
| 2020-04-29 | 2019 | Andrew Saik Former Chief Financial Officer | 370,000 | 0 | 0 | 0 | 0 | 679,363 |
| 2020-04-29 | 2018 | Andrew Saik Former Chief Financial Officer | 370,000 | 166,500 | 70,632 | 0 | 0 | 1,267,622 |
| 2020-04-29 | 2019 | Gregory L. Conn, Ph.D. Chief Scientific Officer | 169,167 | 0 | 0 | 0 | 38,184 | 668,954 |
| 2020-04-29 | 2018 | Gregory L. Conn, Ph.D. Chief Scientific Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | W. Bradford Middlekauff Former SVP, General Counsel and Secretary | 121,742 | 156,400 | 0 | 0 | 0 | 278,142 |
| 2020-04-29 | 2018 | W. Bradford Middlekauff Former SVP, General Counsel and Secretary | 347,700 | 157,470 | 42,351 | 0 | 11,000 | 1,349,947 |
| 2020-04-29 | 2019 | Brian A. Leuthner Former Chief Executive Officer | 110,417 | 0 | 0 | 0 | 896,583 | 1,007,000 |
| 2020-04-29 | 2018 | Brian A. Leuthner Former Chief Executive Officer | 530,000 | 318,000 | 143,846 | 0 | 10,800 | 4,358,946 |
| 2019-08-16 | 2017 | W. Bradford Middlekauff SVP, General Counsel and Secretary | 328,000 | 97,580 | 0 | 0 | 10,800 | 782,162 |
| 2019-08-16 | 2018 | Brian A. Leuthner Chief Executive Officer | 530,000 | 318,000 | 0 | 0 | 7,488 | 4,355,634 |
| 2019-08-16 | 2017 | Brian A. Leuthner Chief Executive Officer | 500,000 | 255,000 | 0 | 0 | 10,800 | 2,527,631 |
| 2019-08-16 | 2018 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Officer | 150,750 | 0 | 0 | 0 | 272,179 | 443,017 |
| 2019-08-16 | 2017 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Officer | 402,000 | 153,765 | 0 | 0 | 10,800 | 1,291,059 |
| 2019-08-16 | 2018 | Herbert J. Faleck Chief Medical Officer | 416,000 | 187,200 | 0 | 0 | 11,000 | 1,312,063 |
| 2019-08-16 | 2017 | Herbert J. Faleck Chief Medical Officer | 400,000 | 153,000 | 0 | 0 | 10,800 | 1,288,293 |
| 2019-08-16 | 2018 | Andrew Saik Chief Financial Officer | 370,000 | 166,500 | 0 | 0 | 0 | 1,267,622 |
| 2019-08-16 | 2017 | Andrew Saik Chief Financial Officer | 61,667 | 0 | 0 | 0 | 0 | 1,656,069 |
| 2019-08-16 | 2018 | W. Bradford Middlekauff SVP, General Counsel and Secretary | 347,700 | 157,470 | 0 | 0 | 11,000 | 1,349,947 |
| 2018-04-25 | 2017 | Herbert J. Faleck, D.O. Chief Medical Officer | 400,000 | 0 | 0 | 153,000 | 10,800 | 1,288,293 |
| 2018-04-25 | 2016 | Herbert J. Faleck, D.O. Chief Medical Officer | 377,100 | 0 | 0 | 169,695 | 0 | 1,200,728 |
| 2018-04-25 | 2017 | Brian A. Leuthner President and Chief Executive Officer | 500,000 | 0 | 0 | 255,000 | 10,800 | 2,527,631 |
| 2018-04-25 | 2016 | Brian A. Leuthner President and Chief Executive Officer | 467,500 | 0 | 0 | 266,475 | 0 | 1,840,694 |
| 2018-04-25 | 2017 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Officer | 402,000 | 0 | 0 | 153,765 | 10,800 | 1,291,058 |
| 2018-04-25 | 2016 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Officer | 390,000 | 0 | 0 | 175,500 | 0 | 974,505 |
| 2017-04-28 | 2015 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Offıcer | 311,250 | 0 | 0 | 166,674 | 0 | 2,544,955 |
| 2017-04-28 | 2015 | Herbert J. Faleck, D.O. Chief Medical Offıcer | 311,250 | 0 | 0 | 148,155 | 0 | 945,144 |
| 2017-04-28 | 2016 | Brian A. Leuthner President and Chief Executive Offıcer | 467,500 | 0 | 0 | 266,475 | 0 | 1,840,694 |
| 2017-04-28 | 2015 | Brian A. Leuthner President and Chief Executive Offıcer | 376,250 | 0 | 0 | 268,643 | 0 | 2,871,212 |
| 2017-04-28 | 2016 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Offıcer | 390,000 | 0 | 0 | 175,500 | 0 | 974,505 |
| 2017-04-28 | 2016 | Herbert J. Faleck, D.O. Chief Medical Offıcer | 337,100 | 0 | 0 | 150,840 | 0 | 1,141,873 |
| 2016-04-28 | 2014 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Officer | 275,000 | 78,375 | 0 | 0 | 0 | 690,618 |
| 2016-04-28 | 2014 | Herbert J. Faleck, D.O. Chief Medical Officer | 280,000 | 79,800 | 0 | 0 | 0 | 1,144,759 |
| 2016-04-28 | 2015 | Brian A. Leuthner President and Chief Executive Officer | 376,250 | 268,643 | 0 | 0 | 0 | 2,871,212 |
| 2016-04-28 | 2014 | Brian A. Leuthner President and Chief Executive Officer | 330,000 | 141,075 | 0 | 0 | 0 | 837,225 |
| 2016-04-28 | 2015 | R. Loch Macdonald, M.D., Ph.D. Chief Scientific Officer | 311,250 | 166,674 | 0 | 0 | 0 | 2,544,995 |
| 2016-04-28 | 2015 | Herbert J. Faleck, D.O. Chief Medical Officer | 311,250 | 148,155 | 0 | 0 | 0 | 954,144 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
